Propel Bio Management

Propel Bio Management as of June 30, 2024

Portfolio Holdings for Propel Bio Management

Propel Bio Management holds 24 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Applied Therapeutics Comm (APLT) 19.9 $31M 6.6M 4.67
Plains Gp Holdings Lp-cl Comm (PAGP) 16.8 $26M 1.4M 18.82
Tscan Therapeutics Comm (TCRX) 7.9 $12M 2.1M 5.85
Madrigal Pharmaceuticals Comm (MDGL) 7.8 $12M 43k 280.16
Achieve Life Sciences Comm (ACHV) 7.5 $12M 2.5M 4.70
Phathom Pharmaceuticals I Comm (PHAT) 5.8 $9.0M 870k 10.30
Akero Therapeutics Comm (AKRO) 5.0 $7.7M 328k 23.46
Avidity Biosciences Comm (RNA) 4.7 $7.3M 179k 40.85
Ardelyx Comm (ARDX) 4.4 $6.9M 925k 7.41
Abeona Therapeutics Comm (ABEO) 3.4 $5.3M 1.2M 4.24
Fulcrum Therapeutics Comm (FULC) 3.0 $4.7M 750k 6.20
Athira Pharma Comm (ATHA) 2.6 $4.0M 1.5M 2.65
Telesat Corp Comm (TSAT) 2.2 $3.3M 366k 9.10
Verrica Pharmaceuticals I Comm (VRCA) 2.0 $3.1M 425k 7.29
Kura Oncology Comm (KURA) 1.7 $2.7M 130k 20.59
Eiger Biopharmaceuticals Comm 1.2 $1.9M 146k 12.65
Syndax Pharmaceuticals In Comm (SNDX) 1.1 $1.7M 83k 20.53
Kymera Therapeutics Comm (KYMR) 1.1 $1.7M 56k 29.85
Kayne Anderson Energy Inf Comm (KYN) 1.0 $1.5M 147k 10.33
Trevi Therapeutics Comm (TRVI) 0.5 $775k 260k 2.98
Fidelity Inv Mmtrsy 1 680 Comm 0.2 $317k 317k 1.00
Cybin Comm (CYBN) 0.1 $230k 850k 0.27
Maat Pharma Saca Comm 0.0 $9.8k 1.4k 7.16
Chinook Therapeutics Comm 0.0 $9.8k 79k 0.12